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Ruth Langton
Glutamate is the primary excitatory neurotransmitter in the mammalian central nervous
system. It is of particular interest because of its supposed role in the processes of learning
and memory, and also because of its potential toxic effects that have been linked to
neurodegenerative diseases, such as Alzheimer’s and Parkinson’s. Although glutamate is
necessary for normal cell functioning, high levels of glutamate receptor activation can
result in cell death, a phenomenon known as excitotoxicity. It has been suggested that
glutamate also plays an important role in the insect and crustacean nervous systems,
allowing for the examination of excitotoxicity in these organisms. The current study aims
to determine the effect of high concentrations of glutamate on the neurite outgrowth of
cultured fiddler crab (Uca pugilator) cells. Cells were obtained from the x-organ, a
neurohemal organ located in the crustacean eyestalk, and were cultured for 24 hours in
simple culture medium. After 24 hours, cells exhibiting neurite outgrowth were
photographed and treated with one of four concentrations of glutamate. The treatment
groups included: control with 0 mM glu, 0.1 mM glu, 1 mM glu, and 10 mM glu. After
another 24 hours, the cells were photographed a second time and the neurite outgrowth
was measured and compared. Higher concentrations of glutamate had a negative effect on
neurite outgrowth, causing the neurites to retract or slow their growth. Glutamate
receptors were also located in the x-organ cells using immunocytochemistry with
fluorescence. This study provides insight into the workings of the crustacean nervous
system and shows that fiddler crabs are a model organism in which to examine the effects
of excitotoxicity, which may lead to future knowledge about the mechanisms of
neurodegenerative diseases.

Introduction
Glutamate is the primary excitatory neurotransmitter in the mammalian central
nervous system (Sheldon and Robinson, 2007). It is an amino acid that acts
predominantly on depolarizing post-synaptic receptors (Nicholls, 1993). Compared to all
other neurotransmitters, the levels of glutamate are extremely high in the mammalian
central nervous system, about 1000-fold higher than many other important
neurotransmitters, such as dopamine and serotonin (Sheldon and Robinson, 2007).
Neurotransmitters such as glutamate have been implicated in the development of
neuronal morphology and brain neuroarchitecture, and are important to the overall
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functioning of the nervous system (Mattson, 1988). Glutamate is of particular interest
because of its supposed role in the processes of learning and memory (Bliss and Dolphin,
1982; Collingridge and Singer, 1990) and because of its potential toxic effects that are
associated with neurodegenerative diseases, such as Parkinson’s and Alzheimer’s
(Rothman and Olney, 1986; Choi, 1988; Meldrum and Garthwaite, 1990; Nicholls, 1993;
Sheldon and Robinson, 2007).
It has been shown that excessive activation of glutamate receptors can result in
cell death, a phenomenon known as excitotoxicity (Choi, 1992; Coyle and Puttfarcken,
1993; Doble, 1999; Sheldon and Robinson, 2007). This excitotoxicity has been
associated with a number of acute and chronic neurodegenerative diseases. These
diseases include: amyotrophic lateral sclerosis (ALS), Alzheimer’s disease, Huntington’s
disease and Parkinson’s disease, as well as a few more acute insults such as epilepsy and
cerebral ischemia (Rothman and Olney, 1986; Choi, 1988; Mattson et al., 1988; Meldrum
and Garthwaite, 1990; Sheldon and Robinson, 2007). Since there is no evidence for
extracellular metabolism of glutamate, it is believe that this amino acid needs to be
cleared from the extracellular space by transporters (Sheldon and Robinson, 2007).
Alterations in the expression or function of these glutamate transporters have been
implicated in a variety of neurological disorders, but it is not clear if changes in glutamate
transporters precede neurodegeneration or result from it (Sheldon and Robinson, 2007).
There is some evidence that antioxidants can rescue cells from death induced by
excitotoxicity. Ueda et al. (2002) show that increased levels of extracellular glutamate at
the initiation seizures induced with kanic acid is associated with the generation of free
radicals which cause oxidative stress. Antolin et al. (2002) show the protective effects of
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melatonin in an experimental model of Parkinson’s disease. It was hypothesized that cell
death is derived from free radical damage and that anti-oxidants, such as melatonin, may
reverse these effects (Antolin et al., 2002).
The toxic effects of high concentrations of glutamate, particularly with respect to
neurite outgrowth, have been examined in a number of studies. Diffusible factors such as
neurotransmitters are known to regulate both the rate and direction of neurite outgrowth
in culture (Ryan et al., 2006). Mattson et al. (1988) found that dendrites of isolated
hippocampal pyramidal neurons were suppressed by glutamate application. Owen and
Bird (1997) investigated the effects of glutamate on the development of spinal cord
neurons grown in culture and found that the application of glutamate resulted in a
reduction in both the rate of outgrowth and the motility of neurites. Ryan et al. (2006)
demonstrated that focal application of glutamate to neurite growth cones of descending
brain neurons from larval lamprey inhibited neurite outgrowth or caused neurite
retraction. This study suggested that these effects were due to calcium influx via both
voltage-gated calcium channels and ligand-gated channels (Ryan et al., 2006). Graf and
Cooke (1994) also found that calcium metabolism influenced neurite outgrowth in
cultured crustacean x-organ neurons, the subject of this study.
Rival et al. (2004) examined the toxicity of glutamate in the insect brain by
silencing a high-affinity glutamate transporter in Drosophila. The experimenters
observed behavioral changes, a poor ability to fly, and contracted neurites in sampled
brain sections (Rival et al., 2004). This evidence suggests that decreasing glutamate
buffering capacity in the Drosophila brain has neurotoxic effects similar to those seen in
mammals. Although the insect and crustacean nervous systems are similar, the potential
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neurotoxic effects of glutamate in the crustacean brain have not been previously studied.
It is known, however, that glutamate is an integral part of the crustacean nervous system
and that the motorneurones in the crayfish locomotory system are glutamatergic (Watson
et al., 2000). Watson et al. (2000) show that glutamate may have more than one role in
the arthropod central nervous system, with glutamate-immunoreactive synapses
representing a mixture of excitatory and inhibitory connections.
Glutamate receptors mediate most excitatory transmission in the brain (Nicholls,
1993; Sheldon and Robinson, 2007). There are both ionotropic and metabotropic
glutamate receptors and there is evidence that both types of glutamate receptors exist in
the invertebrate brain (Wafford and Sattelle, 1989; Brugess and Derby, 1997; Cleland and
Selverston, 1998; Duan and Cooke, 2000; Krenz et al., 2000; Levi and Selverston, 2006).
Ionotropic receptors consist of groups of transmembrane ion channels that open and close
in response to a chemical messenger such as a neurotransmitter. Metabotropic receptors
are indirectly linked to ion channels through signal transduction mechanisms, often Gproteins. Ionotropic glutamate receptors are broken into two categories: NMDA (Nmethyl D-aspartate) and AMPA/kainite (α-amino-3-hydroxy-5-methyl-4isoxazolepropionic acid) that both have glutamate-gated ion channels (Nicholls, 1993).
These receptors are made up of structurally related subunits, GluR1-7 (Nicholls, 1993;
Santa Cruz Biotechnology, 2008). AMPA/kainite receptors are primarily responsible for
fast, excitatory neurotransmission by glutamate and consist of subunits GluR1-4, where
as NMDA receptors, subunits GluR5-7, are characterized by slow kinetic and a high
permeability for Ca2+ ions (Nicholls, 1993; Santa Cruz Biotechnology, 2008).
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Duan and Cooke (2000) suggest that ionotropic glutamate receptors exist in the xorgan/sinus gland of crab peptide-secretory neurons. The x-organ/sinus gland is a
neurohemal organ located in the crustacean eyestalk just beneath the exoskeleton (Bunt
and Ashby, 1967; Nagano, 1986). The x-organ is comprised of a cluster of about 150
large neurons that sends axons to the sinus gland via the sinus gland nerve (Cooke 1985;
Nagano and Cooke, 1987; Cooke et al., 1989). The x-organ/sinus gland in the crustacean
nervous system is analogous to the hypothalamus in the mammalian brain (Weatherby,
1981; Nagano, 1985; Cooke, 1985; Nagano and Cooke, 1987; Duan and Cooke, 2000)
and releases several different types of neurohormones that control processes such as
molting and growth, gonadal development, limb regeneration, and the metabolism of
proteins and lipids (Cooke, 1985; Weatherby, 1981). This structure provides an excellent
model for the study of hormones and neurotransmitters because x-organ cells can be
cultured and grown in simple medium. Cooke et al. (1989) found that these cells show
immediate outgrowth after adhering to the substrate and can continue to grow for about
seven days. It was suggested that these cells may exhibit this immediate outgrowth as a
result of already active synthetic, transport, and secretory mechanisms for growth.
Ionotropic glutamate receptors may exist in the x-organ/sinus gland of the crab
nervous system. It was determined that γ-amnio-butyric acid (GABA), the primary
inhibitory neurotransmitter in the mammalian central nervous system, and glutamate
activate different receptors that mediate Cl- conductance within the cell based on a
difference in desensitization during Glu and GABA application (Duan and Cooke, 2000).
A number of studies suggest the existence of metabotropic glutamate receptors (mGluR)
in the spiny lobster’s stomatogastric ganglion and that these mGluRs are similar to those
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described in mammals (Levi and Selverston, 2006; Krenz et al., 2000). Although there is
evidence suggesting that both ionotropic and metabotropic glutamate receptors exist in
the crustacean nervous system, they have not been previously located using
immunocytochemistry.
The current study aims to examine the potential neurotoxic effects of glutamate in
the crustacean brain and to locate the ionotropic glutamate receptors in cultured xorgan/sinus gland cells of fiddler crabs. Specifically, I wanted to determine if the
presence of glutamate in high concentrations affects neurite outgrowth of cultured Uca
pugilator cells.

Methods
Crab housing and care. Fiddler crabs (Uca pugilator) were purchased from Gulf
Specimen Marine Laboratory (Panacea, FL) and housed in clear plastic tanks with
Croalife® artificial seawater with both terrestrial and aquatic terrains available. Crabs
were fed Purina Cat Chow® every other day, and water was changed after each feeding.

Tissue Dissection. Dissection procedures were adapted from Cooke et al. (1989). Sterile
crab saline solution for crab dissection was prepared by combining 500 ml HPLC
chromasolv water, 14.3 g NaCl, 0.41 g KCl, 0.95 g CaCl2, 2.64 g MgCl2, and 1.19 g
HEPES. The solution was adjusted to pH 7.4 with 1 M NaOH, vacuum-filtered, treated
with 10 mL stabilized penicillin-streptomycin-neomycin solution and stored at 8ºC.
Prior to performing the eyestalk dissection, the fiddler crabs were anesthetized by
cooling at 8ºC for at least 10 minutes. All dissection tools and plates were rinsed in 70%
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ethanol prior to dissection. Eyestalks were removed and immediately submerged in
sterile crab saline. Incisions were made through the outer carapace on the lateral sides of
each eyestalk up to the cornea, and the top portion of the carapace was lifted to reveal the
underlying eyestalk muscular and neural tissue. The neural tissue was dissected away
from the eyestalk and examined to locate the light blue, opalescent sinus gland on the
medulla terminalis.
X-organ-containing tissue on the opposite side of the medulla terminalis was
removed and placed in Ca2+ and Mg2+ free saline with 0.1% trypsin. The sterile Ca++free, Mg++-free saline was prepared by combining 500 ml HPLC chromasolv water, 15.45
g NaCl, 0.41 g KCl and 1.19 g HEPES. The trypsin digest solution was adjusted to pH
7.4 with 1 M NaOH, vacuum filtered and stored at 8ºC. X-organ tissue was gently stirred
in the trypsin solution for 1 hour. The trypsin digested protein attachments between cells,
allowing the cells to dissociate without being damaged. Prior to dissection, the trypsin
solution was prepared by combining 200 μl trypsin 10x solution and 5 ml of Ca2+ and
Mg2+ free saline in an Erlenmeyer flask and swirling to mix.

Cell culture. Culture medium was adapted from Cooke et al. (1989). To prepare the
culture medium, a concentrated crab saline solution was made by combining 500 mL
HPLC chromasolv water, 16.609 g NaCl, 0.476 g KCl, 1.109 g CaCl2, 3.066 g MgCl2,
and 2.303 g HEPES. The super concentrated crab saline solution was then combined
with 500 ml L-15 medium leibovitz and 21.624 g D-glucose for a final concentration
isosmotic to crab hemolymph, 850 mOsm. The culture medium was adjusted to pH 7.4
with 1 M NaOH and vacuum filtered. Ten ml of 200 mM L-glutamine and 10 mL
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penicillin-streptomycin-neomycin solution was added to the final solution, which was
stored at 8ºC.
Each piece of x-organ tissue was transferred to a 200 µL drop of culture medium
(osmolality 840 mM) in 35mm MatTek Corporation a glass-bottom culture dish. The
tissue was then broken apart using forceps. Cells were allowed to adhere to the glassbottom and then approximately 1 hour later 3 mL of culture medium was added to each
dish. The cultures were housed in darkness and high humidity.

Treatments. A stock solution of 10 mM glutamate was made and combined with regular
culture medium to attain the desired glutamate concentration for each treatment group.
Treatment groups included: control (0 mM glu), 0.1 mM glu, 1 mM glu, and 10 mM glu.
Cells were cultured and allowed to grow for 24 hours in regular culture medium. After
the first 24 hours, the original culture medium was removed using a glass Pasteur pipette
and was replaced with the control or glutamate solution of the appropriate concentration.
Cells were allowed to grow for another 24 hours while bathed in the glutamate solution.
Five trials were conducted with each of the four treatment groups.

Measurement of neurite growth. Cells were viewed with a Zeiss Axiovert 200
microscope with phase contrast and photographed with AxioVision software; an example
of one of these images can be seen in Figure 1. Photographs were taken immediately
after 24 and 48 hours of growth, before and after glutamate application respectively.
Approximately 30 cells from each dish were photographed, totaling about 150 cells per
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treatment group. With AxioVision software, the perimeter of the neurite-encompassing
area around each cell was traced as well as the cell body (example in Figure 2).

Analysis. In order to standardize measurements to account for differing cell sizes, cell
body measurements were subtracted from the neurite area and then divided by the cell
body area.

Statistical Analysis. A two-way ANOVA was used to determine the differences among
treatments (before and after glutamate application) and among culture dishes within
treatments, with the Holm-Sidak method for pairwise comparisons when the data did not
pass the Equal Variance Test. Data was indexed and the factors used for this test were:
treatment group (24 or 48 hours) and dish number within each group (dishes 1-5). An
overall comparison of the four treatment groups was done using a one-way ANOVA and
Dunn’s method for multiple comparisons. Statistics were performed using SigmaStat
software, version 2.0.

Glutamate and Melatonin. One trial run was conducted to determine if melatonin has a
protective effect on cells treated with glutamate. Cells were cultured in simple medium
following the procedure outlined above and were left to incubate for 24 hours. Cells
were photographed, as described above. Culture medium was removed using a glass
Pasteur pipette and was replaced with 3.2 mL of 10 mM glutamate stock solution and 3.6
µL of 1 mM melatonin. Culture dishes were left to incubate for another 24 hours and
were photographed using the procedure above.
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Immunocytochemistry with fluorescence. Cells were stained for glutamate receptors
using a rabbit antibody GluR (H-301 that was purchased from Santa Cruz Biotechnology,
Inc.) and was prepared at a dilution of 1:50 when combined with PBS buffer. This
antibody was used for the detection of ionotropic glutamate receptors 1, 2, 3, and 4.
FITC-conjugated goat anti-rabbit secondary antibody (Santa Cruz Biotechnology, Inc.)
was prepared with a 1:50 dilution.

Fixing cells. Cells were dissected in the same method as stated above and were fixed
using formaldehyde. Culture medium was removed from the dish using a glass Pasteur
pipette and cells were treated with 3.7% formaldehyde for 15 minutes. Formaldehyde
was removed and cells were rinsed with PBS buffer. The buffer was removed and 1M
glycine was added for 15 minutes and then removed. Cells were rinsed with PBS buffer,
PBS was removed, and 0.5% triton-X 100 was added for 10 minutes. Triton-X 100 was
removed and cells were rinsed with PBS buffer. PBS was removed and 1% goat serum
(10 µL serum into 1mL of PBS buffer) was added for 30 minutes. Cells were rinsed with
PBS buffer.

Antibody Labeling. 200µL of glutamate receptor (GluR-1, 2, 3, 4) primary antibody
(GluR (H-301)) was added to each dish. Cells were incubated for approximately 1 hour
in the dark at room temperature. Primary antibody was removed and cells were rinsed
with PBS buffer. 200µL of rhodamine phallodin (for actin labeling) and 100µL of goat
anti-rabbit (secondary antibody) were added to each dish and cells incubated of
approximately 30 minutes in the dark at room temperature. Rhodamine and the
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secondary antibody were removed and cells were rinsed with PBS. A few drops of
Prolong Gold antifade fixative with DAPI (for nuclear staining) was added to each dish.
Dishes were stored in an aluminum-wrapped box at room temperature.

Photographing. Cells were located using a Zeiss Axiovert 200 fluorescence microscope.
Photographs were taken using Axiovision software. A confocal microscope at the Mount
Desert Island Biological Laboratory was used to photograph whole chunks of eyestalk
tissue that had been fixed and stained using the procedure above.

Results
Control cells showed more growth after 48 hours than after 24 hours, however,
this difference was not significant (Figure 3, p>0.05). No significant difference among
dishes within each control time period (24 and 28 hours) was found (p>0.05).
Cells treated with 0.1mM glutamate showed a slight but insignificant (p>0.05)
increase after 48 hours of growth when cells were bathed in a 0.1mM glutamate solution
at 24 hours (Figure 4). No significant difference was seen between dishes within each
treatment (p>0.05).
Cells in the 1mM glutamate treatment group also showed a slight but insignificant
(p>0.05) increase from 24 to 48 hours, after being bathed in 1mM glutamate (Figure 5).
No significant difference was seen between culture dishes within each treatment
(p>0.05).
A significant difference was seen between cells in the 10 mM glutamate group
before and after glutamate application (after 24 and 48 hours respectively) (p<0.01). A
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decrease in standardized neurite outgrowth was seen after the application of 10 mM
glutamate (Figure 6). No significant difference was found between culture dishes within
each treatment (p>0.05).
When comparing the four treatment groups, there was no significant difference
seen among any of the groups after 24 hours of growth prior to glutamate application
(Figure 7, p>0.05). After 48 hours (24 hours after the application of glutamate), neurite
outgrowth decreased with increasing concentrations of glutamate, compared to the
control, with 10 mM glutamate cells showing the least outgrowth (Figure 8). The 0.1
mM and 1 mM glutamate treatment groups did not differ significantly from the control
(p>0.05) and are not significantly different from each other (p>0.05). The 10 mM
glutamate treatment group is significantly different from all other treatment groups and
the control (p<0.05).
Immunocytochemistry indicated the potential presence of glutamate receptors in
the fiddler crab neurons using green (FITC) fluorescence. Glutamate receptors appear to
be located on the cell membrane of the cell body and also in the membrane of the neurites
(Figure 9). As well as staining the cultured cells, I also labeled larger pieces of tissue
from the x-organ to determine the general localization pattern of potential glutamate
receptors. Based on the fluorescence staining, the glutamate receptors appear to be
located in the x-organ/sinus gland of the fiddler crab eyestalk (Figure 10), as well as in
other neural tissue.
Cells in the glutamate plus melatonin trial group showed normal neurite
outgrowth after the first untreated 24 hours of growth in simple culture medium. After
being treated with melatonin and glutamate, at 48 hours, the cells had almost all lysed
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and all that was left was debris from the cell bodies. This pattern recurred in all three
different culture dishes.

Discussion
The results of this study suggest glutamate has an effect on neurite outgrowth and
also that glutamate receptors exist in fiddler crab x-organ cells. The lower concentrations
of glutamate (0.1 mM and 1 mM) had no significant impact on neurite outgrowth, but the
highest concentration, 10 mM, significantly decreased outgrowth which is assumed to be
a result of excitotoxicity. I expected that lower levels of glutamate would not affect
normal cell growth, because they are more normal physiological concentrations at which
glutamate is necessary for mammalian cell functioning (Nicholls, 1993). These results
show that high levels of glutamate are necessary to cause excitotoxicity in the x-organ
cells.
Previous studies have also used high concentrations of glutamate and seen a toxic
effect on cells. Ryan et al. (2006) used focal application of glutamate at concentrations
of 5 mM and 25 mM to larval lamprey descending brain neurons. This study found that
the application of glutamate inhibited outgrowth of treated neurites, but did not affect
other neurites from the same neuron (Ryan et al, 2006). However, when glutamate was
applied directly to the cell body, all the neurites from the cell were inhibited (Ryan et al.,
2006), which corresponds with the results of the my study. Owen and Bird (1997) used
concentrations of glutamate ranging from 1 to 100 µM when studying its effects on
mouse spinal cord neurons and found a significant inhibition of neurite growth. This
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suggests that higher concentrations of glutamate are necessary for outgrowth inhibition in
crustaceans than in mammals.
Immunocytochemisty with fluorescence was used in this study to attempt to
locate glutamate receptors, which appear to have been successfully labeled in both the
cell body and the neurites of x-organ cells. This provides support for the inhibitory effect
of glutamate on neurite outgrowth because it indicates that glutamate is able to enter and
interact with the cell. Further studies are needed to more fully establish the presence of
these receptors.
After I determined that 10 mM glutamate significantly decreased neurite
outgrowth in cultured cells, I added melatonin as another variable in the experiment to
determine if melatonin, an antioxidant, has the ability to rescue cells treated with
glutamate. Melatonin is known to have widespread antioxidant actions including the
direct scavenging of free radicals and activation of enzymes in antioxidant pathways (Tan
et al, 1993; Reiter et al., 2007). Antolin, et al. (2002) suggests that melatonin prevents
cell death as well as damage caused by oxidative stress in a mouse model of Parkinson’s
disease and indicate that melatonin may prevent neurotoxin damage in general.
If cells were rescued from the excitotoxicity caused by glutamate, they would not
show reduced outgrowth, or may show more outgrowth after 48 hours. For example,
previous studies in the Tilden lab (Cuttler, 2007) showed both a neurite growth enhancing
effect and a separate antioxidant, neuroprotective effect of melatonin alone on x-organ
cells. However, in a trial run of this experiment, these cells lysed after being treated with
both glutamate and melatonin, and all cells that were present in the dish after 48 hours
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did not have visible neurites. The reason for this detrimental effect of the combination of
melatonin and glutamate is unclear and is an area that requires further research.
In sum, I was able to locate glutamate receptors in the x-organ cells of fiddler
crabs, which implicates these crabs as a powerful model system for studying glutamatemediated neurodegeneration. These fiddler crabs can be used in future studies to add to
the body of research about neurodegenerative disease and excitotoxicity.
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Figure 1. Control cell after 48 hours of growth in simple culture medium. Photographed
using a Zeiss Axiovert 200 microscope at 400X magnification.

Figure 2. Control cell after 48 hours of growth in simple culture medium. Photographed
using a Zeiss Axiovert 200 microscope at 400X magnification and analyzed using
AxioVision software. Measurements represent cell body size (269.59µm2) and total
neurite encompassing area (2593.29 µm2).
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Figure 3. Mean neurite outgrowth of the control cells, standardized for differing cell
body sizes, after 24 and 48 hours of growth in simple culture medium (+/-SE).
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Figure 4. Mean neurite growth of cells, standardized for differing cell body sizes, in the
0.1 mM glutamate treatment group after 24 and 48 hours of growth, before and after
glutamate application respectively (+/- SE).
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Figure 5. Mean neurite growth of cells, standardized for differing cell body sizes, in the
1 mM glutamate treatment group after 24 and 48 hours of growth, before and after
glutamate application respectively (+/- SE).
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Figure 6. Mean neurite growth of cells, standardized for differing cell body sizes, in the
10 mM glutamate treatment group after 24 and 48 hours of growth, before and after
glutamate application respectively (+/- SE).
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Figure 7. Neurite growth, standardized for differing cell body size, after 24 hours and
before glutamate application to all treatment groups (+/- SE).
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Figure 8. Neurite growth, standardized for differing cell body size, after 48 hours of
growth and after glutamate application to all treatment groups (+/- SE).
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Figure 9. Cluster of six cultured cells labeled with green fluorescence for glutamate
receptors (GluR-1, 2, 3, 4).
(a)

(b)

x-organ/sinus gland area

Figure 10. X-organ/sinus gland area of the fiddler crab eyestalk stained for (a) cell
nuclei with DAPI blue fluorescence (b) glutamate receptors (GluR-1, 2, 3, 4) with fitc
green fluorescence.
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